Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sevoflurane Sedation in Patients With Septic Shock
Sponsor: University of Zurich
Summary
Recent in vivo studies from others as well as the investigators group demonstrated that volatile anesthetics immunomodulate sepsis and improve outcome. Also, several clinical trials have convincingly shown that application of a volatile anesthetic provides protection in patients undergoing major surgery. Patients with sepsis are intubated and ventilated and therefore need sedation. So far, most ICU centers use intravenously applied sedatives in these patients. In the proposed study, we will switch sedation from an intravenous to a volatile anesthetic for a short period of time to explore if sepsis markers improve within the following 120 hours upon sevoflurane conditioning.
Official title: Sevoflurane Sedation: A Potentially Promising Immunomodulation in Patients With Septic Shock
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
153
Start Date
2026-01
Completion Date
2027-11
Last Updated
2025-04-01
Healthy Volunteers
No
Conditions
Interventions
Sevoflurane
Included patients, randomized in experimental group, intravenous sedation will be interrupted and followed by a 4 hour sedation with the volatile anesthetic sevoflurane.
Control Group
Included patients randomized in control group, intravenouse sedation is continued with propofol
Locations (4)
Kantonasspital Münsterlingen
Münsterlingen, Switzerland
Stadtspital Triemli
Zurich, Switzerland
University Hospital of Zurich
Zurich, Switzerland
Waidspital Zürich
Zurich, Switzerland